Aerovate Therapeutics Net Change in Investments - Total 2020-2025 | JBIO
Aerovate Therapeutics net change in investments - total from 2020 to 2025. Net change in investments - total can be defined as the total change in long term and short term investments
Aerovate Therapeutics Annual Net Change in Investments - Total
(Millions of US $) |
| 2024 |
$56 |
| 2023 |
$12 |
| 2022 |
$7 |
| 2021 |
$-113 |
| 2020 |
$N/A |
| 2019 |
$N/A |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.008B |
$0.000B |
|
Aerovate Therapeutics Inc. is a clinical stage biopharmaceutical company. It focused on developing drugs for cardiopulmonary disease. The company's product pipeline consist AV-101. Aerovate Therapeutics Inc. is based in BOSTON.
|
